PRMT1 and leukemia: PRMT1 is also involved in the interaction of many transcription factors and promoters, and the overexpression and abnormal splicing of PRMT1 directly affects the occurrence of tumors, including breast cancer, lung cancer, bladder cancer, leukemia, and colorectal cancer [10–14].